首页> 外国专利> MOLECULE ASSOCIATED WITH ONSET OF GOUT, AND METHOD AND KIT FOR EVALUATING DIATHESIS OF URIC ACID-RELATED DISEASES AND INFLAMMATION-RELATED DISEASES, AND INSPECTION OBJECT AND DRUG

MOLECULE ASSOCIATED WITH ONSET OF GOUT, AND METHOD AND KIT FOR EVALUATING DIATHESIS OF URIC ACID-RELATED DISEASES AND INFLAMMATION-RELATED DISEASES, AND INSPECTION OBJECT AND DRUG

机译:与痛风发作有关的分子,评估尿酸相关疾病和炎症相关疾病,检查对象和药物的素质的方法和工具包

摘要

To specify a molecule associated with the onset of gout so as to provide a method for evaluating a diathesis of uric acid-related diseases and a diathesis of inflammation-related diseases, an evaluation kit for carrying out the method, an inspection object, and a drug, on the basis of the molecule specified above, for contributing to the early treatment and prevention of the uric acid-related diseases and inflammation-related diseases. The molecule includes any one protein and cDNA of CNIH2-PACS1, ALDH2, MYL2-CUX2, GCKR, MAP3K11, NPT4, ABCG2, HIST1H2BF/HIST1H4E, HIST1H2BE/HIST1H4D and FAM35A, or proteins of combination thereof with GLUT9, NPT1, URAT1, or NXRN2, and is capable of selectively inducing gout. A molecule includes protein and cDNA of an ABCG2 variant and is capable of selectively and ATP-dependently decreasing urate excretion.
机译:为了确定与痛风发作有关的分子,以提供用于评估与尿酸有关的疾病的素质和与炎症有关的疾病的素质的方法,用于执行该方法的评估试剂盒,检查对象以及治疗方法。基于上述分子的药物,有助于早期治疗和预防与尿酸有关的疾病和与炎症有关的疾病。该分子包括CNIH2-PACS1,ALDH2,MYL2-CUX2,GCKR,MAP3K11,NPT4,ABCG2,HIST1H2BF / HIST1H4E,HIST1H2BE / HIST1H4D和FAM35A的任何一种蛋白质和cDNA,或其与GLUT9,NPT1,RAT的组合蛋白质NXRN2,并且能够选择性地诱发痛风。分子包含ABCG2变体的蛋白质和cDNA,并且能够选择性地和ATP依赖性地减少尿酸盐排泄。

著录项

  • 公开/公告号EP3095865A4

    专利类型

  • 公开/公告日2018-03-14

    原文格式PDF

  • 申请/专利号EP20150737793

  • 发明设计人 TAKADA TAPPEI;

    申请日2015-01-19

  • 分类号A61K38;C12N15/09;A61K48;A61P19/06;A61P29;C07K14/47;C12N5/10;C12Q1/68;G01N33/68;

  • 国家 EP

  • 入库时间 2022-08-21 13:17:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号